Spero Therapeutics, Inc. (SPRO) Social Stream



Spero Therapeutics, Inc. (SPRO): $12.26

-0.24 (-1.92%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Spero Therapeutics Inc (SPRO) Price Targets From Analysts

Use the tables below to see what analysts covering Spero Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $40 $25 $30.666 $12.67 142.04%
5 $47 $25 $34.75 $12.67 174.27%
5 $40 $25 $30.666 $12.67 142.04%

The Trend in the Analyst Price Target


Over the past 30 weeks, SPRO's average price target has gone up $1.75.

SPRO reports an average of 111.29% for its upside potential over the past 18 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-15 4 40 25 30.666 16.41 86.87%
2021-11-15 5 40 25 30.666 16.41 86.87%
2021-11-15 4 47 25 34.750 16.41 111.76%
2021-11-15 5 47 25 34.750 16.41 111.76%
2021-08-07 7 70 8 33.860 14.14 139.46%
2021-04-25 2 70 8 33.000 13.18 150.38%
2021-01-16 6 70 8 30.880 16.45 87.72%
2020-05-30 NA 28 7 20.600 NA NA%

SPRO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


Over the past 14 months, SPRO's average broker recommendation rating improved by 0.03.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SPRO as an investment opportunity.

  • In the context of all US stocks, Spero Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 258.67% of them.
  • In terms of how Spero Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -118.5% of that group.
  • In terms of how Spero Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is higher than 86.26% of that group.
  • In the context of stocks in the small market cap category, Spero Therapeutics Inc's average analyst price target is greater than 211.68% of them.

Stocks similar to Spero Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PYXS, CELU and TIL.

Is SPRO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7274 seconds.